International Clinical Trial: Safety and efficacy of KD025 in reducing intraocular pressure: a double-blind, randomized, controlled clinical trial

Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132677) titled 'Safety and efficacy of KD025 in reducing intraocular pressure: a double-blind, randomized, controlled clinical trial' on Sept. 17.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: Sanmenxia Central Hospital

Condition: Glaucoma

Intervention: Experimental group:Give KD025 eye drops

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-09-17

Target Sample Size: Experimental group:10;Control group:10;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=340913

Published by HT Digital Content Services with pe...